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RESUMO: A toxoplasmose é uma zoonose de distribuição mundial, com grande 
importância na medicina humana e veterinária. Esta enfermidade é causada pelo 
Toxoplasma gondii, pode ser transmitida através da ingestão de cistos teciduais em 
carne infectada, a ingestão de alimentos ou água contaminados com oocistos e pela 
forma congênita, por taquizoítos que atravessam a placenta da mãe infectada para 
o feto. Os animais podem ser fonte direta ou indireta da infecção para o homem. 
Felinos em particular (hospedeiros intermediários ou definitivos para os parasitas) 
têm um papel importante na epidemiologia deste agente, como eles podem eliminar 
oocistos no ambiente doméstico. Portanto, a comunidade científica tem dedicado 
grandes esforços para avaliar a ocorrência de anticorpos de Toxoplasma gondii em 
felinos. O objetivo desta revisão é descrever as manifestações clínicas da 
toxoplasmose, para abordar o papel dos gatos na propagação da doença, bem 
como para discutir métodos de diagnóstico, medidas terapêuticas, a profilaxia e 
controle da doença. 
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ABSTRACT: Toxoplasmosis is a zoonosis distributed worldwide, which is of great 
importance in human and veterinary medicine. Toxoplasmosis, caused by 
Toxoplasma gondii, can be transmitted through the ingestion of tissue cysts in 
infected meat, ingestion of food or water contaminated with oocysts and 
congenitally, by tachyzoites crossing the placenta from the infected mother to the 
fetus. Felines in particular (intermediate or definitive hosts for the parasites) have an 
important role in the epidemiology of this agent, as they can eliminate oocysts in the 
domestic environment. The aim of this review is to describe clinical manifestations of 
toxoplasmosis, to address the role of cats in the spread of the disease, as well as to 
discuss methods of diagnosis, therapeutic measures, prophylaxis and control of this 
disease. 
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INTRODUCTION 
 
Felines (definitive hosts of Toxoplasma 
gondii) can eliminate fecal oocysts. 
These are highly infectious parasite 
forms that evolved to tolerate 
environmental adversities Cats defecate 
on soft earth or sand and bury their 
feces, which can remain in place for 
months. Cats generally do not present 
diarrhea during the period of oocysts 
excretion; hence, unless the cat is ill, 
little or no fecal residue is adhered to 
their perianal region. Because of its 
careful cleaning habits, fecal matter is 
not found in the pelage of clinically 
normal animals; therefore the possibility 
of transmission to humans by the act of 
touching or petting a cat is minimal or 
nonexistent. It is important to note that 
oocysts eliminated by cats, need to be in 
the extracorporeal environment for at 
least one day, under particular 
temperature and humidity conditions, to 
sporulate and become infective. 
In this review we aim to provide 
information on the role of cats take in the 
cycle of this important zoonosis, 
suggesting guidelines to the community 
on how to best avoid human infections. 
 
 
FELINE TOXOPLASMOSIS 
 
The life cycle of T. gondii was first 
elucidated in the late 1960s/ early 1970s 
(Frenkel et al., 1970; Hutchison et al., 
1968; Hutchison et al., 1970; Hutchison 
et al., 1971). These initial works 
demonstrated the shedding of infective 
Toxoplasma life forms by cats. Cats can 
act as definitive (Frenkel et al., 1970) or 
intermediate host, sheltering the extra-
intestinal parasite stages (Dubey, 2002; 
Dubey et al., 1996). 
T. gondii is transmitted via 3 primary 
routes: ingestion of tissue cysts, 
contamination through oocysts from 
infected cat feces, or congenital 
infection. In rare instances 
toxoplasmosis can also be transmitted 
through the ingestion of contaminated 
milk, transfer of body fluids or organ 
transplantation (Dubey, 1986; Miro et al., 
2004; Powell et al., 2001). 
Immunosuppression in cats with 
toxoplasmosis by concomitant infections 
with feline leukemia virus (FeLV) or 
feline immunodeficiency virus (FIV), 
leads to a suppression of CD4 + and 
CD8 +, reduction in the expression of 
interleukins (IL-2, IL-6, TNF-ã), 
reactivation of latent disease and causes 
re-shedding of fecal oocysts 
(Akhtardanesh et al., 2010; Lappin et al., 
1993; Sukhumavasi et al., 2012; 
Swinger et al., 2009; Tiao et al., 2013). 
Types of feline of Toxoplasma 
 
 
PATHOGENESIS AND DIAGNOSIS 
 
Cats experimentally infected with T. 
gondii are often asymptomatic: few 
animals get sick and deaths due to 
Toxoplasma infection are rare (Omata et 
al., 1990; Sato et al., 1993). However, 
close scrutiny of a large number of cats 
diagnosed with toxoplasmosis 
(confirmed by histopathology), revealed 
lung infections (97.7%), neuropathy 
(96.4%), hepatitis (93.3%), pancreatitis 
(84.4%), cardiovascular (86.4%) and 
ophthalmic changes (81.5%) in most 
cats (Dubey and Carpenter, 1993). 
Kittens infected during gestation (via the 
placenta) or through the milk of infected 
queens can undergo inflammatory 
processes that affect the liver, lungs and 
central nervous system. These are 
clinically displayed as uveitis, lethargy, 
depression, ascites, encephalitis, 
hypothermia and sudden death. 
Experimental infection of pregnant cats 
with the parasite leads to abortion and 
high neonatal mortality (Dubey and 
Hoover, 1977; Dubey et al., 1977; 
Dubey et al., 1996; Powell et al., 2001; 
Sakamoto et al., 2009; Sato et al., 
1993). In adults with primary or recurrent 
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infection, clinical symptoms are 
anorexia, lethargy, dyspnea, pneumonia, 
intermittent fever, emaciation, vomiting, 
diarrhea, hyperesthesia, stiff gait, 
lameness, neurological deficits, 
dermatitis and death (Dubey and Lappin, 
2006). Furthermore, T. gondii infections 
can cause jaundice, cholangitis, ascites, 
hepatitis and pancreatitis (leading to 
hepato-biliary compromise) (Harvey and 
Greeffydd-Jones, 2009; Smart et al., 
1973). Under conditions of pancreatitis, 
there is elevation of serum amylase and 
lipase as well as reduction in serum 
calcium (Dubey and Lappin, 2006). 
Toxoplasmosis can cause tissue 
impairment, leading to hypo-
proteinemia, hypo-globulinemia, and 
increased serum enzymatic activities of 
alanine transaminase (ALT), alkaline 
phosphatase (ALP), bilirubin and hyper-
gammaglobulinemia (Dubey and Lappin, 
2006). 
In the acute stage of the disease, 
radiographic examination of the thorax 
of affected animals can generally detect 
a diffuse interstitial alveolar pattern with 
lobar distribution. In severely 
compromised animals, it is possible to 
observe a diffuse and homogeneous 
pattern due to alveolar coalescence. 
Abdominal radiography of animals 
severely affected by toxoplasmosis 
show intestinal masses, increased 
mesenteric lymph nodes and ascites; 
whereas ultrasonography frequently 
show tissue or organ enlargement, 
suggestive of granuloma formation. 
Tomography and magnetic resonance 
imaging are further techniques that can 
be employed in the clinical to detect 
damages to the central nervous system 
of infected animals (Dubey and Lappin, 
2006). 
Toxoplasmosis can also lead to ocular 
symptoms, caused by parasite invasion 
of the uveal tract, retina and optic nerve, 
triggering inflammation with exudative 
retinal displacement, iridocyclitis, iritis, 
chorioretinitis, aqueous flare, keratic 
precipitates, crystalline lens dislocation 
and glaucoma (Dubey and Lappin, 
2006). Ocular symptoms can occur in 
cats with or without systemic infections.  
The principal symptoms of acute 
toxoplasmosis are non-regenerative 
anemia, leukocytosis with neutrophilia or 
lymphocytosis, monocytosis and 
eosinophilia (Dubey and Lappin, 2006). 
Necropsy of animals which succumbed 
to toxoplasmosis frequently show severe 
abnormalities in the central nervous 
system such as: cerebral necrosis, 
discoloration of nervous tissue, 
cerebellar necrosis, atrophy, 
encephalitis, non-suppurative menigo-
encephalomyelitis and gliosis, with 
eventual compromise of peripheral 
nerves. Necropsy can also show: 
pulmonary necrosis, hepatic and 
mesenteric lymph node necrosis (Dubey 
and Lappin, 1998). However, the 
unambiguous confirmation of the 
diagnosis depends on the isolation of 
the parasite and positive serodiagnosis 
(Lapppin, 2004; Carvalho, 2007). 
Once infected, animals frequently 
shelter bradyzoites in their tissues, 
which encourages a long-term humoral 
immune response. This allows the 
detection of antibodies against T. gondii 
by indirect immunofluorescence as well 
as by direct agglutination test, 
hemagglutination test and enzyme 
immunoassay, in diagnosis and 
epidemiological survey of this zoonosis 
(Dubey and Lappin, 2006; Zhang, et al., 
2000). 
Anfray et al., (2005) described a positive 
diagnosis of T. gondii infection in a 
female cat, by employing 
immunohistochemistry and polymerase 
chain reaction (PCR) on samples 
prepared from cutaneous nodules. Park 
and colleagues (Park et al., 2007) 
described histopathologic and molecular 
characterization of T. gondii infections 
from samples collected from a mammary 
gland nodule. The cytological 
examination of this sample showed 
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pyogranulomatous, necrotizing 
panniculitis, vasculitis and mastitis with 
clusters of tachyzoites, confirming of the 
diagnosis by molecular techniques. 
Dubey and Powell, (2012) reported the 
occurrence of six million T. gondii 
oocysts in a fecal sample from a 6-year-
old male cat with clinical toxoplasmosis 
symptoms (lethargy, anorexia, fever and 
diarrhea) and with positive serology for 
T. gondii (1:800 by the modified 
agglutination test). The authors further 
genotyped the parasites reporting, for 
the first time, a type I infection in the 
United States of America (USA). 
The occurrence of fecal T. gondii 
oocysts is low as they are released for 
only one to two weeks during the initial 
stages of the disease. One method to 
facilitate the detection of oocysts in the 
feces of cats and hence provide a 
parasitological diagnosis is the Sheather 
method (centrifugal-flotation in sucrose). 
However, microscopic examination of 
samples prepared using this method is 
unable to morphologically distinguish 
oocysts from the evolutionarily 
conserved T. gondii, Sarcocystis, 
Frenkelia and Besnoitia. This 
discrimination can only be achieved by 
molecular techniques (Dubey and 
Lappin, 2006). 
T. gondii tachyzoites, life form 
responsible for multiplying the 
population of parasites in the host, can 
be detected by cytology of body tissues 
and fluids samples, such as blood, 
cerebrospinal fluid, peritoneum and 
bronchoalveolar lavage samples. The 
tachyzoites may also be isolated from 
samples of ascitic fluid or pleural 
effusion (Brownlee and Sellon, 2001; 
Dubey and Lappin, 2006). 
 
 
 
 
EPIDEMIOLOGY OF FELINE 
TOXOPLASMOSIS 
 
Multiple research groups have 
performed epidemiological studies of 
feline Toxoplasmosis. In Table 1 we 
summarize some of the epidemiological 
studies performed over the last 15 
years, with special emphasis to 
infections on Brazil. 
 
 
 
Dubey et al. (2004), isolated 37 T. gondii 
samples from 54 domestic cats from 
Paraná, in the city of Santa Isabel do 
Ivaí, during an outbreak of human 
toxoplasmosis. Most of these isolates, 
15 of which were of type I and 22 of type 
III, were virulent in mice, however, there 
was no correlation between the tested 
genotype and virulence. 
In the same year, Pena et al. (2004) 
isolated 47 samples of T. gondii from 71 
cats in São Paulo, finding that 72.4% of 
the animals were infected with type I, 
25.5% were infected with type III and 
2.1% had mixed infection (types I and 
III). In contrast to the work reported by 
Dubey (2004), Pena et al., (2004) 
showed that in mice, Type I parasites 
had a significantly higher virulence (97% 
mortality) than type III (42% mortality). 
Bresciani et al. (2007) conducted studies 
to investigate the presence of antibodies 
against T. gondii in cats from the 
northwestern region of the state of São 
Paulo, and observed a higher incidence 
of T. gondii antibodies with aging 
(probably due to the cumulative 
exposure to the parasites). 
Coelho et al. (2011) also performed 
epidemiological studies of cats infected 
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with T. gondii and found a strong 
correlation between disease incidence 
and factors such as: postnatal infection, 
diet and presence of rodents in the 
environment. Sobrinho et al. (2012) 
investigated concomitant infections with 
Toxoplasma and Leishmania and found 
no correlation between the occurrences 
of either parasite.  
 
 
TREATMENT AND PROFILAXIS 
 
Clindamycin hydrochloride, administered 
orally or parenterally, is effective in the 
treatment of systemic toxoplasmosis and 
can reduce the elimination of oocysts by 
cats.  It is used toxoplasmosis treatment 
in animals and humans, and indicated 
for the treatment of pregnant queens. 
This drug has good intestinal absorption, 
is transported through the blood brain 
barrier and leads to clinical improvement 
of affected animals within 24 to 48 hours 
from the onset of treatment. In this time 
frame, it is possible to observe a return 
of appetite and normalization of the body 
temperature. With further treatment, 
after weeks there are reports of re-
establishment of the operation of cranial 
and spinal nerves, as well as the 
resolution of polymyositis. Clinical 
improvement of ocular damage is also 
described after a week of treatment with 
clindamycin hydrochloride. However, 
excessive doses may cause local 
irritation in the digestive system, with 
side effects such as anorexia, vomiting 
and diarrhea (LAPPIN, 2004; (Dubey 
and Lappin, 2006; Swinger et al., 2009)). 
Glucocorticoids are generally 
contraindicated in the treatment of T. 
gondii infections, since this class of 
compounds can exacerbate the 
systemic symptoms of the disease. 
However, this class of compounds can 
be advised for the topical treatment (in 
combination with clindamycin chloride) 
of ocular lesions (Dubey and Lappin, 
2006; Harvey and Greeffydd-Jones, 
2009). Clindamycin treatment can also 
be combined with folic acid 
supplementation in cases where there is 
bone marrow compromised by the 
infection (Dubey and Lappin, 2006). 
Trimethoprim-sulfametaxol combination 
therapy is also effective on the treatment 
of toxoplasmosis, in particular on the 
treatment of ocular lesions in human 
(Dubey and Lappin, 2006). In addition to 
trimethoprim-sulfametaxol, sulfadiazine-
trimethoprim combination therapy is also 
recommended for the control of 
toxoplasmosis in small animals (Papich, 
2009). Barbosa et al.(2012) studied the 
in vitro and in vivo activity of 
enrofloxacin in the treatment of 
toxoplasmosis, demonstrated its 
effectiveness and low toxicity.  
Enroflacin can therefore become an 
alternative treatment against 
toxoplasmosis. 
A simple recommended method to 
minimize the risk of contamination of 
cats and humans by Toxoplasma is to 
discard cat stools daily, as oocysts 
require at least 24 hours to sporulate 
and become infectious. It is also 
important to minimize opportunities for 
coprophagia by animals, as well as the 
control of insects and rodents in the 
environment. Furthermore, neither 
humans nor cats should consume raw or 
undercooked meat or raw milk, and care 
should be taken to ensure the 
consumption of clean fruit and vegetable 
and suitably treated water (Monteiro, 
2010). 
 
 
CONCLUSION 
 
Toxoplasmosis it is a zoonosis of 
worldwide distribution that causes a 
range of clinical symptoms, from the 
absence of any obvious abnormality, to 
death of the infected host. Thus, 
diagnosis, treatment and control of 
toxoplasmosis present a great challenge 
to the veterinary in a feline clinic. 
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Although is possible for T. gondii to 
survive and multiply in the absence of 
cats, evidence gathered so far indicates 
that this host is of pivotal importance in 
the transmission of toxoplasmosis 
worldwide. Thus, the veterinarian plays 
a vital role in the control of this disease. 
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